Flow Cytometry market has been estimated at USD 4270 Million in 2018 and is projected to reach USD 7030 Million by 2023, at a CAGR of 10.5% during the forecast period from 2018 to 2023. Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser. In the current life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics markets, flow cytometry offers some of the brightest promise for growth and innovation.
The market for Flow Cytometry is mainly driven due to increasing applications as a result of technological advancements in the flow cytometry instruments and devices, availability of high speed clinical grade cell sorters for clinical development and stem cell research. Also, rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers is driving the market growth. But, the market growth can be restrained due to high cost associated with instruments and reagents, and lack of awareness about the potential benefits of the technique.
Global market for Flow Cytometry is segmented based on Technology, Product, Application and End-users. By Technology, the market is further sub-segmented into Cell-based and Bead-based. By Product, the market is further sub-segmented into Reagents & Consumables, Flow Cytometry Instruments (Cell Analyzers, Cell Sorters). By Application, the market is further sub-segmented into Research, Clinical, and Industrial. By End-users, the market is further sub-segmented into Commercial Organizations, Research Institutes, Clinical Testing Labs, Hospitals and Academic Institutions & Medical Schools. The cell-based flow cytometry technology accounts for the largest share, by technology. Research applications segment is accounts for the largest share, by application. The commercial organizations end-user segment accounts for the largest share, by end user.
Geographically, Global market for Flow Cytometry is segmented into North America, Asia Pacific, Latin America, Europe, and Middle-East and Africa. North America is the biggest market in terms of market share across the globe, followed by Europe. The market in North America is highly driven due to factors like increasing application of flow cytometry techniques in cancer research, increasing adoption of low cost and compact flow cytometers in clinical diagnostics and research laboratories, and increasing quality of infrastructure for laboratory and clinical research. The Flow Cytometry market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to increasing development and production of new biologics, vaccines, and drugs, expanding medical treatment for infectious and chronic diseases, increasing median age of the population and increasing focus on attracting international and domestic players in the market.
Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc., are the major players of Global Flow Cytometry market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Cell-based
5.1.3 Bead-based
5.1.4 Y-o-Y Growth Analysis, By Technology
5.1.5 Market Attractiveness Analysis, By Technology
5.1.6 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Reagents & Consumables
5.2.3 Flow Cytometry Instruments
5.2.3.1 Cell Analyzers
5.2.3.2 Cell Sorters
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3 Application
5.3.1 Introduction
5.3.2 Research Applications
5.3.2.1 Pharmaceutical & Biotechnology
5.3.2.2 Immunology
5.3.2.3 Apoptosis
5.3.2.4 Cell Cycle Analysis
5.3.2.5 Cell Sorting
5.3.2.6 Cell Viability
5.3.2.7 Other Research Applications
5.3.3 Clinical Applications
5.3.3.1 Cancer
5.3.3.2 Immunodeficiency Diseases
5.3.3.3 Hematology
5.3.3.4 Organ Transplantation
5.3.3.5 Other Clinical Applications
5.3.4 Industrial Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.3 End-users
5.3.1 Introduction
5.3.2 Commercial Organizations
5.3.3 Hospitals
5.3.4 Academic Institutions & Medical Schools
5.3.5 Clinical Testing Labs
5.3.6 Research Institutes
5.3.7 Y-o-Y Growth Analysis, By End-users
5.3.8 Market Attractiveness Analysis, By End-users
5.3.9 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By Application
6.1.3.5 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By Application
6.1.4.5 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By Application
6.1.5.5 By End-users
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton, Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Beckman Coulter, Inc.
8.3 Thermo Fisher Scientific, Inc.
8.4 Merck KGaA
8.5 Sysmex Partec GmbH
8.6 Luminex Corporation
8.7 Miltenyi Biotec GmbH
8.8 Bio-Rad Laboratories, Inc.
8.9 Sony Biotechnology
8.10 Life Technologies Corporation Inc.
8.11 EMD Millipore Corporation
8.12 Miltenyi Biotec
8.13 Thermo Fischer Scientific
8.14 Agilent Technologies, Inc.
8.15 Affymetix Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
